CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 5,265,165 shares at $2.01 ($10,582,982)
- 4 Open-market buy 10% owner bought 5,265,165 shares at $2.01 ($10,582,982)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.27 ($22,700)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.57 ($12,850)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.05 ($41,000)
- 4 Open-market buy Director bought 50,500 shares at $2.03 ($102,495)
- 4 Open-market buy Director bought 500 shares at $1.98 ($990)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $2.00 ($9,975)
- 4 Derivatives Options or other derivatives
Page 4 of 10 · 194 filings